Schneider H - Search Results

1

Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use.

Moerer O, Schmid A, Hofmann M, Herklotz A, Reinhart K, Werdan K, Schneider H, Burchardi H. Moerer O, et al. Among authors: schneider h. Intensive Care Med. 2002 Oct;28(10):1440-6. doi: 10.1007/s00134-002-1429-9. Epub 2002 Aug 17. Intensive Care Med. 2002. PMID: 12373469

2

A new concept for DRG-based reimbursement of services in German intensive care units: results of a pilot study.

Neilson AR, Moerer O, Burchardi H, Schneider H. Neilson AR, et al. Among authors: schneider h. Intensive Care Med. 2004 Jun;30(6):1220-3. doi: 10.1007/s00134-004-2168-x. Epub 2004 Feb 24. Intensive Care Med. 2004. PMID: 14985961

3

Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Burchardi H, Schneider H. Burchardi H, et al. Among authors: schneider h. Pharmacoeconomics. 2004;22(12):793-813. doi: 10.2165/00019053-200422120-00003. Pharmacoeconomics. 2004. PMID: 15294012 Review.

4

A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units.

Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, Burchardi H. Moerer O, et al. Among authors: schneider h. Crit Care. 2007;11(3):R69. doi: 10.1186/cc5952. Crit Care. 2007. PMID: 17594475 Free PMC article.

5

Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock.

Neilson AR, Burchardi H, Schneider H. Neilson AR, et al. Among authors: schneider h. J Crit Care. 2005 Sep;20(3):239-49. doi: 10.1016/j.jcrc.2005.03.003. J Crit Care. 2005. PMID: 16253792

6

The economic burden of sepsis in Austria.

Schmid A, Schneider H. Schmid A, et al. Among authors: schneider h. Wien Klin Wochenschr. 2002 Dec 30;114(23-24):1023-4; author reply 1024. Wien Klin Wochenschr. 2002. PMID: 12635473 No abstract available.

7

Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany.

Neilson AR, Burchardi H, Chinn C, Clouth J, Schneider H, Angus D. Neilson AR, et al. Among authors: schneider h. J Crit Care. 2003 Dec;18(4):217-27. doi: 10.1016/j.jcrc.2003.10.005. J Crit Care. 2003. PMID: 14691895

8

Burden of illness imposed by severe sepsis in Germany.

Schmid A, Burchardi H, Clouth J, Schneider H. Schmid A, et al. Among authors: schneider h. Eur J Health Econ. 2002;3(2):77-82. doi: 10.1007/s10198-002-0095-8. Eur J Health Econ. 2002. PMID: 15609133

9

Economic burden of illness imposed by severe sepsis in Austria.

Schmid A, Schneider H, Adlof A, Smolle KH, Edelmann G, Sporn P, Frass M, Sumann G, Koller W, Schobersberger W. Schmid A, et al. Among authors: schneider h. Wien Klin Wochenschr. 2002 Aug 30;114(15-16):697-701. Wien Klin Wochenschr. 2002. PMID: 12602114

10

Economic burden of obesity and its comorbidities in Switzerland.

Schmid A, Schneider H, Golay A, Keller U. Schmid A, et al. Among authors: schneider h. Soz Praventivmed. 2005;50(2):87-94. doi: 10.1007/s00038-004-4067-x. Soz Praventivmed. 2005. PMID: 15900961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,882 results

Search Page